prednimustine - CISMeF

Preferred Label : prednimustine;

MeSH definition : Ester of CHLORAMBUCIL and PREDNISOLONE used as a combination alkylating agent and synthetic steroid to treat various leukemias and other neoplasms. It causes gastrointestinal and bone marrow toxicity.;

CISMeF synonym : pharmacia brand of prednimustine;

DeCS synonym : St r ocyt;

MeSH hyponym : stéréocyt; Leo-1031; stereocyt; NSC-134087; NSC 134087; NSC134087; Sterecyt; Leo 1031; Leo1031;

MeSH CAS label : Pregna-1,4-diene-3,20-dione, 21-(4-(4-(bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy)-11,17-dihydroxy-, (11beta)-;

MeSH Related Number : 29069-24-7 (Prednimustine);

Registry Number MeSH : 29069-24-7;

Wikipedia link : https://en.wikipedia.org/wiki/Prednimustine;

Codes EINECS : 249-410-3;

Is substance : O;

UNII : 9403SIO2S8;

InChIKey : HFVNWDWLWUCIHC-GUPDPFMOSA-N;

Details

Origin ID

D011238;

UMLS CUI

C0032949;

ATC code(s)
- prednimustine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Prednimustine [ICHI extension code]
CISMeF manual mappings
- prednimustine [Substance BNPC]
Pharmacological action(s)
- antineoplastic agents, alkylating [MeSH Descriptor]
Record concept(s)
- Leo-1031 [MeSH concept]
- NSC-134087 [MeSH concept]
- prednimustine [MeSH concept]
- stereocyt [MeSH concept]
Related MeSH Supplementary Concept(s)
- CEP protocol [MeSH Supplementary Concept]
- IMEP protocol [MeSH Supplementary Concept]
- PNMF protocol [MeSH Supplementary Concept]
- PmM protocol [MeSH Supplementary Concept]
- VAP regimen [MeSH Supplementary Concept]
- VMP regimen [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Prednimustine [ICD-11 Extension code]
- Prednimustine [NCIt concept]
- prednimustine [ATC Code]
- prednimustine [Substance BNPC]
Validated automatic mappings to BTNT
- prednimustine [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients